Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Galantamine: therapeutic effects beyond cognition.

¹Neurology Department, Hospital Clinic, University of Barcelona, Spain. blesa@medicina.ub.es

Dementia and Geriatric Cognitive Disorders

|September 6, 2000

Summary

Galantamine treatment improves daily functioning and behavioral disturbances in Alzheimer's disease (AD) patients. This Alzheimer's drug also reduces caregiver burden without disrupting sleep quality.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders.

Scientific reports·2020

Same author

Diagnostic validity of the Alzheimer's disease functional assessment and change scale in mild cognitive impairment and mild to moderate Alzheimer's disease.

Dementia and geriatric cognitive disorders·2014

Same author

Changes in cerebral glucose metabolism with normal aging.

European journal of neurology·2013

Same author

PICOGEN: five years experience with a genetic counselling program for dementia.

Neurologia (Barcelona, Spain)·2010

Same author

Cardiac sympathetic impairment parallels nigrostriatal degeneration in Probable Dementia with Lewy Bodies.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2010

Same author

Problem-solving abilities and frontal lobe cortical thickness in healthy aging and mild cognitive impairment.

Journal of the International Neuropsychological Society : JINS·2010

Area of Science:

Neurology
Pharmacology
Geriatrics

Background:

Alzheimer's disease (AD) is characterized by cognitive decline, impacting daily living, behavior, and caregivers.
Clinically meaningful outcomes like the Disability Assessment for Dementia (DAD) and Neuropsychiatric Inventory (NPI) are crucial for assessing AD treatments.
Galantamine, a novel AD treatment, offers a dual mechanism of action: nicotinic receptor modulation and acetylcholinesterase inhibition.

Purpose of the Study:

To review the efficacy of galantamine in improving daily functioning and behavioral disturbances in Alzheimer's disease patients.
To assess the impact of galantamine on caregiver burden and sleep quality.
To highlight galantamine's sustained benefits in managing Alzheimer's disease.

Main Methods:

Review of clinical studies evaluating galantamine in Alzheimer's disease patients.
Assessment of outcomes using scales such as Disability Assessment for Dementia (DAD), Neuropsychiatric Inventory (NPI), and Pittsburgh Sleep Quality Index (PSQI).
Comparison of galantamine treatment groups with placebo groups regarding patient function, behavior, and caregiver time.

Main Results:

Galantamine treatment led to significantly better outcomes in activities of daily living (ADL) compared to placebo over 5 months.
Twelve months of galantamine treatment preserved patients' functional abilities.
Galantamine significantly improved behavioral disturbances and reduced caregiver time spent assisting patients, without negatively impacting sleep quality.

Conclusions:

Galantamine demonstrates positive and sustained effects on patient behavior and daily functioning in Alzheimer's disease.
The benefits of galantamine extend to reducing the burden on caregivers.
Galantamine offers a favorable safety profile, particularly regarding sleep quality, compared to other cholinergic treatments.

Related Experiment Videos